BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ha MW, Hou KZ, Liu YP, Yuan Y. Effect of staurosporine on cycle human gastric cancer cell. World J Gastroenterol 2004; 10(2): 161-166 [PMID: 14716814 DOI: 10.3748/wjg.v10.i2.161]
URL: https://www.wjgnet.com/1007-9327/full/v10/i2/161.htm
Number Citing Articles
1
Jennifer Sigmond, Andries M. Bergman, Leticia G. Leon, Willem J.P. Loves, Eveline K. Hoebe, Godefridus J. Peters. Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductaseAnti-Cancer Drugs 2010; 21(6): 591 doi: 10.1097/CAD.0b013e32833a3543
2
Alexandre D.T. Costa, Marco A. Krieger. Evidence for an ATP-sensitive K+ channel in mitoplasts isolated from Trypanosoma cruzi and Crithidia fasciculataInternational Journal for Parasitology 2009; 39(9): 955 doi: 10.1016/j.ijpara.2009.01.002
3
Mollianne McGahren Murray, Tuyen Bui, Michelle Smith, Rozita Bagheri-Yarmand, Hannah Wingate, Kelly K. Hunt, Khandan Keyomarsi. Staurosporine is chemoprotective by inducing G 1 arrest in a Chk1- and pRb-dependent mannerCarcinogenesis 2013; 34(10): 2244 doi: 10.1093/carcin/bgt186
4
Shailendra Kapoor. STAUROSPORINE AND ITS EVOLVING ROLE IN INHIBITION OF GROWTH IN MALIGNANT TUMORSRevista do Instituto de Medicina Tropical de São Paulo 2013; 55(2): 124 doi: 10.1590/S0036-46652013000200016
5
Xi Ding, Cheng Tong, Rong Chen, Xi Wang, Dongyun Gao, Lixia Zhu. Systematic molecular profiling of inhibitor response to the clinical missense mutations of ErbB family kinases in human gastric cancerJournal of Molecular Graphics and Modelling 2020; 96: 107526 doi: 10.1016/j.jmgm.2019.107526